Veracyte
- Market cap
- 3.47B
- P/E (TTM)i
- 30.83
- P/Bi
- 2.50
- EPSi
- 0.82
- Div yieldi
- 0.00%
- 52W posi
- 44%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Veracyte closed at 43.16, down 3.34%. The company carries a market value of roughly 3.47B, the #2330 most valuable US-listed company we track. The 11 analysts covering the stock are, on balance, at Buy, targeting an average of 59.78 (+39%). The shares sit 44% of the way up their 52-week range of 29.46 to 60.91.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 week.
- Recent price momentum is +0.8% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 10.5% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 44.65
- Open
- 44.04
- Day range
- 42.34 - 44.21
- Avg price
- 43.24
- Volume
- 1.21M
- Turnover
- 52.48M
- Turnover ratei
- 1.52%
- Volume ratioi
- 0.91
- Amplitudei
- 4.19%
- 52-week rangei
- 29.46 - 60.91
Valuation
- P/Ei
- 52.63
- P/E (TTM)i
- 30.83
- P/Bi
- 2.50
- EPSi
- 0.82
- Book value / shi
- 17.27
- Net profit
- 65.92M
- Net assets
- 1.39B
Share structure
- Market cap
- 3.47B
- Float capi
- 3.45B
- Shares out
- 80.39M
- Float sharesi
- 79.88M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
29.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+4.24M net over the window
Short interest
- Shares short
- 8.40M
- % of floati
- 10.45%
- Days to coveri
- 7.76
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Veracyte (VCYT)?
Veracyte last traded at 43.16. The quote on this page refreshes every few seconds while US markets are open.
What is Veracyte's market cap?
About 3.47B.
What is the P/E ratio of Veracyte?
The trailing twelve-month P/E is 30.83. The Valuation tab shows it against the stock's own five-year range.
Does Veracyte pay a dividend?
Veracyte does not currently pay a regular dividend.
Is Veracyte a buy according to analysts?
The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 59.78, which implies 38.5% upside from the current price. This is not investment advice.
What is Veracyte's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Veracyte a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 06:26:05 · For reference only, not investment advice and not tailored to your situation.